Dexcom continuous glucose monitor for Type 2 Diabetes
This trial will test whether a continuous glucose monitoring device is helpful for people with type 2 diabetes who are not taking insulin.
- Type 2 Diabetes
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is it possible to join this experiment?
"This trial is searching for 50 individuals who have been diagnosed with type 2 diabetes mellitus and lie between the ages of 18-99."
What is the intended result of this research?
"According to DexCom, Inc., the primary metric of this study will be Change in Glucose Variability as monitored by a Continuous Glucose Monitor. Meanwhile, International Physical Activity Questionnaires (IPAQ), Hemoglobin A1c levels from blood samples and patient responses to the Glucose Monitoring Satisfaction Survey are also being assessed over 0-90 day intervals."
Are there remaining opportunities to join this research trial?
"Per the clinicaltrials.gov database, this medical trial is not actively looking for participants. The first posting was on December 1st 2022 and it has since been updated to October 19th of the same year. Even though registration is currently closed, there are still 1440 other trials recruiting patients at present."
Could people younger than 70 years old partake in this clinical experiment?
"This research is recruiting participants aged 18 years or over, but no older than 99."